Synthetic Thrombin Inhibitors as Anticoagulants Pharmacological Aspects
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 340, 143-171
- https://doi.org/10.1007/978-1-4899-2418-6_13
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Inhibition of thrombin by synthetic hirudin peptidesFEBS Letters, 1990
- Syntheses of Nα-(β-naphthylsulfonylaminoglycyl)-argininamides as potential selective synthetic thrombin inhibitorsEuropean Journal of Medicinal Chemistry, 1988
- Application of gabexate mesilate (FOY) for open heart surgery.Blood & Vessel, 1988
- Plasma antithrombin activity of MD 805 determined by chromogenic substrate during hemodialysis.Blood & Vessel, 1987
- Characteristics of the microsomalN-hydroxylation of benzamidine to benzamidoximeXenobiotica, 1987
- The comparative study on the anticoagulant activities of the synthetic thrombin inhibitor (MD-805) and heparin.Blood & Vessel, 1985
- New approach to regional anticoagulation in hemodialysis using gabexate mesilate (FOY)Critical Care Medicine, 1982
- Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portionBiochemical and Biophysical Research Communications, 1981
- Structure-activity relationship in a series of synthetic thrombin inhibitors: No. 205, No. 407 and No. 700Blood & Vessel, 1980
- Perspectives in the design of small molecule enzyme inhibitors as useful drugsJournal of Theoretical Biology, 1978